The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety

Investigative Radiology

Volumn 47, Issue 9, 2012, Pages 503-510

  Lenhard, Diana C ^a   Pietsch, Hubertus ^a   Sieber, Martin A ^b   Ernst, Rainer ^a   Lengsfeld, Philipp ^a   Ellinghaus, Peter ^a   Jost, Gregor ^a  

^a BAYER PHARMA AG   (Germany)

^b Intendis GmbH   (Germany)

Author keywords

AKI marker; contrast agent retention; osmolality; renal safety; viscosity

Indexed keywords

IODINATED CONTRAST MEDIUM; IODINE; IODIXANOL; IOPROMIDE; MANNITOL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERANCE; IMMUNOFLUORESCENCE; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY SAFETY; MALE; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SAFETY; VISCOSITY;

EID: 84864873484     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318258502b     Document Type: Article

References (31)

1. Morcos SK, Thomsen HS,Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9:1602-1613.
2. Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl. 2006;1:S8YS10.
3. Gries H. X-ray contrast agents: physico-chemical properties. In: Dawson P, Cosgrove D, Grainger R, eds. Textbook of Contrast Media. Oxford, United Kingdom: Isis Medical Media Ltd; 1999:15-22.
4. Speck U. X-ray contrast agents: physico-chemical properties. In: Dawson P, Cosgrove D, Grainger R, eds. Textbook of Contrast Media. Oxford, United Kingdom: Isis Medical Media Ltd; 1999:35-46.
5. Jost G, Lengsfeld P, Lenhard DC, et al. Viscosity of iodinated contrast agents during renal excretion. Eur J Radiol. 2011;80:373-377.
6. Ueda J, Nygren A, Sjoquist M, et al. Iodine concentrations in the rat kidney measured by X-ray microanalysis. Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol. 1998;39:90-95.
7. Jost G, Pietsch H, Lengsfeld P, et al. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination. Invest Radiol. 2010;45:255-261.
8. Seeliger E, Becker K, Ladwig M, et al. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat. Radiology. 2010;256:406-414.
9. Love L, Johnson MS, Bresler ME, et al. The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol. 1994;67:951-957.
10. Yamazaki H, Oi H, Matsushita M, et al. Renal cortical retention on delayed CT after angiography and contrast associated nephropathy. Br J Radiol. 1997;70: 897-902.
11. Jost G, Pietsch H, Sommer J, et al. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Invest Radiol. 2009;44:114-123.
12. Seeliger E, Flemming B, Wronski T, et al. Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol. 2007;18:2912-2920.
13. Beeri R, Symon Z, Brezis M, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int. 1995;47:1806-1810.
14. Heinrich MC, Kuhlmann MK, Grgic A, et al. Cytotoxic effects of ionic highosmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology. 2005;235:843-849.
15. Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol. 1991; 157:1153-1161.
16. Dascalu A, Peer A. Effects of radiologic contrast media on human endothelial and kidney cell lines: intracellular pH and cytotoxicity. Acad Radiol. 1994;1: 145-150.
17. Grainger RG. Osmolality of intravascular radiological contrast media. Br J Radiol. 1980;53:739-746.
18. US Department of Health and Human Devices, FDA, Center for Drug Evaluation and Research. Estimating the maximum safe starting dose in clinical trials for therapeutics in adult healthy volunteers. 2005. Available at: http://www.fda.gov/cder/guidance/index.htm.
19. Nordby A, Tvedt KE, Halgunset J, et al. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microsc. 1990;4:651-664; discussion 664-656.
20. Nordby A, Tvedt KE, Halgunset J, et al. Incorporation of contrast media in cultured cells. Invest Radiol. 1989;24:703-710.
21. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273: 4135-4142.
22. Zhou Y, Vaidya VS, Brown RP, et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008;101:159-170.
23. Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010;28:478-485.
24. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinaseYassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231-1238.
25. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856-863.
26. Paragas N, Qiu A, Zhang Q, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med. 2011;17:216-222.
27. Singer E, Elger A, Elitok S, et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int. 2011;80:405-414.
28. Duymelinck C, Dauwe SE, De Greef KE, et al. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int. 2000;58:1186-1201.
29. Samarakoon R, Overstreet JM, Higgins SP, et al. TGF-A1 Y9 SMAD/p53/USF2 Y9 PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res. 2012;347:117-128.
30. Jost G, Lenhard DC, Sieber MA, et al. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity. Invest Radiol. 2011;46:796-800.
31. Seeliger E, Ladwig M, Sargsyan L, et al. Proof of principle: hydration by lowosmolar mannitol-glucose solution alleviates undesirable renal effects of an isoosmolar contrast medium in rats. Invest Radiol. 2012;47:240-246.